Biography
Michael Keng received his BS and MD degrees from Michigan State University in East Lansing, Michigan. He completed his Internal Medicine residency at University of Southern California in Los Angeles, California, and Hematology and Medical Oncology fellowship at the Cleveland Clinic in Cleveland, Ohio. He then joined the University of Virginia (Charlottesville, Virginia) in 2014. He currently holds a faculty appointment in Medicine in the Division of Hematology/Oncology at University of Virginia. He is the medical director of the inpatient hematology and oncology unit and quality director of the division. His clinical areas of interest are focused on clinical trials in hematologic malignancies, including myelodysplastic syndromes, leukemia, and other myeloid malignancies and bone marrow failures. He has a special interest in treating the elderly population, determining optimal combinations and timing of targeted agents, and studying patient safety and quality improvement.
Research Interest
Myelodysplastic syndromes, leukemia, myeloid malignancies and bone marrow failures.
Biography
Tatiana Massarrah obtained her Degree in Nursing from the Pontifical University of Salamanca, Salus Infirmorum Nursing School 1991. Her professional career has developed as a clinical nurse in the Oncology Department, in its various areas, Medical Oncology, Paliattive Care and Oncohematology and Bone Marrow Transplantation. Stay at the Nebraska Medical Center Omaha (USA) in 2008, participating in an Observership Exchange Program between the Ministry of Health of the Madrid Autonomic Community and the NMC at the Oncology Department In 2008. Currently she coordinates the Oncology Research Unit at the Medical Oncology Department. Advisory and training patients in drugs side effects, adverse events management and care is the area of her job development as part of the clinical research unit team. She also carries out his professional profile teaching other professionals who work in this field and area of expertise.
Research Interest
Oncology, medical oncology, Paliattive care and Oncohematology, bone marrow transplantation.
Biography
As an Oncology and Hematology Clinical Nurse Specialist, I have responsibilities at The Johns Hopkins Hospital and Health System level. I serve as the nurse leader overseeing the content and development of policies related to safe handling, chemotherapy and biotherapy, and vascular access devices (VADs). I chair the Hospital's inter professional vascular access committee. In this role, I am responsible for ensuring that evidence-based practice is used throughout the Institution to guide all aspects of VAD insertion and maintenance to prevent complications, including central line-associated blood stream infections (CLABSIs). Nationally, I am an active member of the Oncology Nursing Society (ONS). I am co-editor of the ONS Safe Handling of Hazardous Drugs Guidelines (in press, 2017) and co-editor for the ONS Chemotherapy and Biotherapy Guidelines and Recommendations for Practice (2014), which has sold over 97,000 copies. These publications are internationally used by nurses to guide evidence-based practice. I serve on the American Society of Clinical Oncology (ASCO) and ONS Chemotherapy Safety Standards Workgroup (2016). These guidelines and standards are extensively used by health care providers who prescribe, dispense, and administer chemotherapy in the U.S and internationally. Additionally, I have presented both nationally and internationally, on the topic of safe handling of hazardous drugs.
Research Interest
Drugs,chemotherapy,clinical oncolog..